SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ZMR'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.39A | 1a4gA-3ckzA:53.6 | 1a4gA-3ckzA:34.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.29A | 1a4gA-4cpnA:75.0 | 1a4gA-4cpnA:94.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.71A | 1a4gA-3ckzA:53.6 | 1a4gA-3ckzA:34.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.12A | 1a4gA-4cpnA:75.0 | 1a4gA-4cpnA:94.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.48A | 1a4gB-3ckzA:53.6 | 1a4gB-3ckzA:34.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.32A | 1a4gB-4cpnA:75.2 | 1a4gB-4cpnA:94.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ILE A 222 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)None | 0.24A | 1a4gB-3ckzA:53.6 | 1a4gB-3ckzA:34.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ASP A 148ARG A 149ILE A 220 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)None | 0.24A | 1a4gB-4cpnA:75.2 | 1a4gB-4cpnA:94.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1F9G_A_ASCA950_0 (HYALURONATE LYASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 7 | ARG A 152ASN A 294ARG A 371ARG A 118 | ZMR A 469 (-3.9A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-2.9A) | 1.44A | 1f9gA-3ckzA:undetectable | 1f9gA-3ckzA:19.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1F9G_A_ASCA950_0 (HYALURONATE LYASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 7 | ARG A 149ASN A 293ARG A 373ARG A 115 | ZMR A 700 (-4.0A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-2.9A) | 1.44A | 1f9gA-4cpnA:undetectable | 1f9gA-4cpnA:20.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.4A)NoneNoneZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.69A | 1l7fA-3ckzA:64.4 | 1l7fA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | GLU A 116LEU A 131ASP A 148ARG A 153TRP A 176ILE A 220ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.2A)NoneNoneZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.48A | 1l7fA-4cpnA:54.2 | 1l7fA-4cpnA:28.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | ZMR A 469 (-2.9A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A) | 0.12A | 1l7fA-3ckzA:64.4 | 1l7fA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7F_A_BCZA801_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 115ARG A 149ARG A 373 | ZMR A 700 (-2.9A)ZMR A 700 (-4.0A)ZMR A 700 (-3.0A) | 0.28A | 1l7fA-4cpnA:54.2 | 1l7fA-4cpnA:28.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 151ARG A 152TRP A 178GLU A 276ARG A 292 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)NoneZMR A 469 (-2.8A)ZMR A 469 (-3.0A) | 1.45A | 1l7gA-3ckzA:64.4 | 1l7gA-3ckzA:47.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNoneZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.69A | 1l7gA-3ckzA:64.4 | 1l7gA-3ckzA:47.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ASP A 148ARG A 149ILE A 220ARG A 222GLU A 225 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)NoneZMR A 700 (-3.8A)ZMR A 700 (-3.5A) | 1.28A | 1l7gA-4cpnA:54.1 | 1l7gA-4cpnA:28.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | LEU A 131ASP A 148ARG A 149ARG A 153TRP A 176ILE A 220ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291TYR A 408 | NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNoneZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.47A | 1l7gA-4cpnA:54.1 | 1l7gA-4cpnA:28.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.4A)NoneNoneZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-4.7A) | 0.74A | 1l7hA-3ckzA:64.4 | 1l7hA-3ckzA:47.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | GLU A 116LEU A 131ASP A 148ARG A 153TRP A 176ILE A 220ARG A 222GLU A 225GLU A 274GLU A 275TYR A 408 | ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.2A)NoneNoneZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-4.6A) | 0.49A | 1l7hA-4cpnA:54.1 | 1l7hA-4cpnA:28.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | ZMR A 469 (-2.9A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A) | 0.11A | 1l7hA-3ckzA:64.4 | 1l7hA-3ckzA:47.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7H_A_BCZA801_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 115ARG A 149ARG A 373 | ZMR A 700 (-2.9A)ZMR A 700 (-4.0A)ZMR A 700 (-3.0A) | 0.26A | 1l7hA-4cpnA:54.1 | 1l7hA-4cpnA:28.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 152ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.42A | 1nncA-3ckzA:63.9 | 1nncA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ARG A 149ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-4.0A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.60A | 1nncA-4cpnA:54.0 | 1nncA-4cpnA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 6 / 12 | ARG A 222ALA A 244GLU A 274GLU A 275ARG A 115TYR A 408 | ZMR A 700 (-3.8A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A)ZMR A 700 (-4.6A) | 1.47A | 1nncA-4cpnA:54.0 | 1nncA-4cpnA:28.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_2 (NEURAMINIDASE N9) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.5A)ZMR A 469 (-3.4A)NoneNone | 0.73A | 1nncA-3ckzA:63.9 | 1nncA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_2 (NEURAMINIDASE N9) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ASP A 148ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-3.3A)ZMR A 700 (-4.2A)NoneNone | 0.15A | 1nncA-4cpnA:54.0 | 1nncA-4cpnA:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CDQ_B_SAMB1500_0 (ASPARTOKINASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 7 | ASP A 193TRP A 176LEU A 131GLU A 116 | NoneNoneNoneZMR A 700 (-3.5A) | 1.05A | 2cdqB-4cpnA:undetectable | 2cdqB-4cpnA:21.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.44A | 2cmlA-3ckzA:64.4 | 2cmlA-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.38A | 2cmlA-3ckzA:64.4 | 2cmlA-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.44A | 2cmlA-4cpnA:54.0 | 2cmlA-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.65A | 2cmlA-3ckzA:64.4 | 2cmlA-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ARG A 149ARG A 153TRP A 176ILE A 220 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.16A | 2cmlA-4cpnA:54.0 | 2cmlA-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.43A | 2cmlB-3ckzA:64.2 | 2cmlB-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.36A | 2cmlB-3ckzA:64.2 | 2cmlB-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.47A | 2cmlB-4cpnA:54.0 | 2cmlB-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.63A | 2cmlB-3ckzA:64.2 | 2cmlB-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ARG A 149ARG A 153TRP A 176ILE A 220 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.19A | 2cmlB-4cpnA:54.0 | 2cmlB-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.43A | 2cmlC-3ckzA:64.2 | 2cmlC-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.47A | 2cmlC-4cpnA:54.1 | 2cmlC-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | GLU A 225ALA A 244ARG A 291ASN A 293TYR A 408 | ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-4.6A) | 1.06A | 2cmlC-4cpnA:54.1 | 2cmlC-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.68A | 2cmlC-3ckzA:64.2 | 2cmlC-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ARG A 149ARG A 153TRP A 176ILE A 220 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.26A | 2cmlC-4cpnA:54.1 | 2cmlC-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.43A | 2cmlD-3ckzA:64.3 | 2cmlD-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.46A | 2cmlD-4cpnA:53.9 | 2cmlD-4cpnA:30.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.67A | 2cmlD-3ckzA:64.3 | 2cmlD-3ckzA:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ARG A 149ARG A 153TRP A 176ILE A 220 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.21A | 2cmlD-4cpnA:53.9 | 2cmlD-4cpnA:30.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.41A | 2f0zA-3ckzA:21.6 | 2f0zA-3ckzA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118TYR A 274GLU A 277ARG A 371TYR A 406 | ZMR A 469 (-2.9A)NoneZMR A 469 (-3.7A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 1.46A | 2f0zA-3ckzA:21.6 | 2f0zA-3ckzA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 156GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-3.4A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.79A | 2f0zA-3ckzA:21.6 | 2f0zA-3ckzA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 156TYR A 274GLU A 277ARG A 371TYR A 406 | ZMR A 469 (-3.4A)NoneZMR A 469 (-3.7A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 1.36A | 2f0zA-3ckzA:21.6 | 2f0zA-3ckzA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 115GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.44A | 2f0zA-4cpnA:25.6 | 2f0zA-4cpnA:23.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 153GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-4.2A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 1.07A | 2f0zA-4cpnA:25.6 | 2f0zA-4cpnA:23.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.45A | 2f10A-3ckzA:8.2 | 2f10A-3ckzA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 115GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.42A | 2f10A-4cpnA:25.7 | 2f10A-4cpnA:23.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 152ARG A 156GLU A 227GLU A 276GLU A 277ARG A 292TYR A 347ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 ( 4.8A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.66A | 2htqA-3ckzA:67.4 | 2htqA-3ckzA:56.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ALA A 244GLU A 274GLU A 275ARG A 115TYR A 408 | ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A)ZMR A 700 (-4.6A) | 1.33A | 2htqA-4cpnA:52.7 | 2htqA-4cpnA:31.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ARG A 149ARG A 153GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.60A | 2htqA-4cpnA:52.7 | 2htqA-4cpnA:31.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.48A | 2htqA-4cpnA:52.7 | 2htqA-4cpnA:31.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151TRP A 178ILE A 222ARG A 224 | ZMR A 469 (-3.5A)NoneNoneZMR A 469 (-4.4A) | 0.36A | 2htqA-3ckzA:67.4 | 2htqA-3ckzA:56.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ASP A 148TRP A 176ILE A 220ARG A 222 | ZMR A 700 (-3.3A)NoneNoneZMR A 700 (-3.8A) | 0.43A | 2htqA-4cpnA:52.7 | 2htqA-4cpnA:31.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ILE A 222ARG A 224GLU A 276ARG A 292TYR A 347TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneZMR A 469 ( 4.6A)NoneZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 ( 4.8A)ZMR A 469 (-4.7A) | 0.67A | 2htuA-3ckzA:68.4 | 2htuA-3ckzA:56.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | GLU A 116LEU A 131ARG A 149ARG A 153TRP A 176SER A 177ILE A 220ARG A 222GLU A 274ARG A 291TYR A 408 | ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneZMR A 700 ( 4.6A)NoneZMR A 700 (-3.8A)ZMR A 700 (-2.7A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.49A | 2htuA-4cpnA:53.3 | 2htuA-4cpnA:31.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | GLU A 225ARG A 149ILE A 220ARG A 291TYR A 408 | ZMR A 700 (-3.5A)ZMR A 700 (-4.0A)NoneZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 1.42A | 2htuA-4cpnA:53.3 | 2htuA-4cpnA:31.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 118ASP A 151GLU A 227ARG A 371 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-2.9A) | 0.29A | 2htuA-3ckzA:68.4 | 2htuA-3ckzA:56.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 115ASP A 148GLU A 225ARG A 373 | ZMR A 700 (-2.9A)ZMR A 700 (-3.3A)ZMR A 700 (-3.5A)ZMR A 700 (-3.0A) | 0.22A | 2htuA-4cpnA:53.2 | 2htuA-4cpnA:31.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.35A | 3b7eA-3ckzA:75.3 | 3b7eA-3ckzA:91.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.24A | 3b7eA-3ckzA:75.3 | 3b7eA-3ckzA:91.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.37A | 3b7eA-4cpnA:53.7 | 3b7eA-4cpnA:32.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.71A | 3b7eA-3ckzA:75.3 | 3b7eA-3ckzA:91.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.12A | 3b7eA-4cpnA:53.7 | 3b7eA-4cpnA:32.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.36A | 3b7eB-3ckzA:75.0 | 3b7eB-3ckzA:91.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.25A | 3b7eB-3ckzA:75.0 | 3b7eB-3ckzA:91.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.38A | 3b7eB-4cpnA:53.7 | 3b7eB-4cpnA:32.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.70A | 3b7eB-3ckzA:75.0 | 3b7eB-3ckzA:91.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.13A | 3b7eB-4cpnA:53.7 | 3b7eB-4cpnA:32.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B9L_A_AZZA1009_1 (SERUM ALBUMIN) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 8 | GLU A 225SER A 177HIS A 133ARG A 115 | ZMR A 700 (-3.5A)ZMR A 700 ( 4.6A)NoneZMR A 700 (-2.9A) | 1.18A | 3b9lA-4cpnA:undetectable | 3b9lA-4cpnA:20.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 10 / 12 | ARG A 115GLU A 116ARG A 149GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-4.0A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.39A | 3ckzA-4cpnA:53.7 | 3ckzA-4cpnA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 6 / 12 | GLU A 225ARG A 149GLU A 274ARG A 291ASN A 293TYR A 408 | ZMR A 700 (-3.5A)ZMR A 700 (-4.0A)ZMR A 700 (-2.7A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-4.6A) | 1.39A | 3ckzA-4cpnA:53.7 | 3ckzA-4cpnA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 6 | ASP A 148ARG A 153TRP A 176ILE A 220ARG A 222 | ZMR A 700 (-3.3A)ZMR A 700 (-4.2A)NoneNoneZMR A 700 (-3.8A) | 0.72A | 3ckzA-4cpnA:53.7 | 3ckzA-4cpnA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 6 | TRP A 176ILE A 220ARG A 222SER A 243 | NoneNoneZMR A 700 (-3.8A)None | 1.17A | 3ckzA-4cpnA:53.7 | 3ckzA-4cpnA:32.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HRD_E_NIOE5660_1 (NICOTINATEDEHYDROGENASE LARGEMOLYBDOPTERINSUBUNITNICOTINATEDEHYDROGENASE MEDIUMMOLYBDOPTERINSUBUNIT) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | GLU A 227GLU A 277TRP A 423 | ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)None | 0.93A | 3hrdA-3ckzA:undetectable3hrdE-3ckzA:undetectable3hrdF-3ckzA:undetectable | 3hrdA-3ckzA:18.953hrdE-3ckzA:18.953hrdF-3ckzA:20.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119LEU A 134ARG A 156TRP A 178GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.4A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.50A | 3k37A-3ckzA:53.8 | 3k37A-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119LEU A 134ARG A 156TRP A 178GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.4A)NoneZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.71A | 3k37A-3ckzA:53.8 | 3k37A-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119LEU A 134TRP A 178ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneNoneZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.36A | 3k37A-3ckzA:53.8 | 3k37A-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119LEU A 134TRP A 178ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneNoneZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.65A | 3k37A-3ckzA:53.8 | 3k37A-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 153TRP A 176ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.2A)NoneZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.43A | 3k37A-4cpnA:75.0 | 3k37A-4cpnA:97.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ARG A 371 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A) | 0.20A | 3k37A-3ckzA:53.8 | 3k37A-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ASP A 148ARG A 149ARG A 373 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-3.0A) | 0.19A | 3k37A-4cpnA:75.0 | 3k37A-4cpnA:97.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178GLU A 227GLU A 277ARG A 292ARG A 371 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.4A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A) | 0.50A | 3k37B-3ckzA:53.6 | 3k37B-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151TRP A 178ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)NoneZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A) | 0.32A | 3k37B-3ckzA:53.6 | 3k37B-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 153TRP A 176ARG A 222GLU A 225ALA A 244GLU A 275ARG A 291ARG A 373 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.2A)NoneZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A) | 0.30A | 3k37B-4cpnA:74.9 | 3k37B-4cpnA:97.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152GLU A 276TYR A 406 | ZMR A 469 (-3.9A)ZMR A 469 (-2.8A)ZMR A 469 (-4.7A) | 0.47A | 3k37B-3ckzA:53.6 | 3k37B-3ckzA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149GLU A 274TYR A 408 | ZMR A 700 (-4.0A)ZMR A 700 (-2.7A)ZMR A 700 (-4.6A) | 0.48A | 3k37B-4cpnA:74.9 | 3k37B-4cpnA:97.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.68A | 3k39A-3ckzA:52.9 | 3k39A-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.73A | 3k39A-3ckzA:52.9 | 3k39A-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.54A | 3k39A-4cpnA:73.8 | 3k39A-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.47A | 3k39A-4cpnA:73.8 | 3k39A-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.64A | 3k39B-3ckzA:53.0 | 3k39B-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.47A | 3k39B-4cpnA:73.9 | 3k39B-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.46A | 3k39B-4cpnA:73.9 | 3k39B-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.67A | 3k39C-3ckzA:53.0 | 3k39C-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.73A | 3k39C-3ckzA:53.0 | 3k39C-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A) | 0.52A | 3k39C-4cpnA:74.0 | 3k39C-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.46A | 3k39C-4cpnA:74.0 | 3k39C-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A) | 0.68A | 3k39D-3ckzA:53.0 | 3k39D-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292ARG A 371 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A) | 0.73A | 3k39D-3ckzA:53.0 | 3k39D-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 222ALA A 244GLU A 274GLU A 275ARG A 115 | ZMR A 700 (-3.8A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A) | 1.23A | 3k39D-4cpnA:73.9 | 3k39D-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373 | ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A) | 0.54A | 3k39D-4cpnA:73.9 | 3k39D-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.66A | 3k39E-3ckzA:53.0 | 3k39E-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.72A | 3k39E-3ckzA:53.0 | 3k39E-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.54A | 3k39E-4cpnA:73.9 | 3k39E-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.45A | 3k39E-4cpnA:73.9 | 3k39E-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.65A | 3k39F-3ckzA:53.0 | 3k39F-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.71A | 3k39F-3ckzA:53.0 | 3k39F-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.53A | 3k39F-4cpnA:73.9 | 3k39F-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.67A | 3k39G-3ckzA:53.0 | 3k39G-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.72A | 3k39G-3ckzA:53.0 | 3k39G-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.53A | 3k39G-4cpnA:73.9 | 3k39G-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.47A | 3k39G-4cpnA:73.9 | 3k39G-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.66A | 3k39H-3ckzA:53.0 | 3k39H-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.72A | 3k39H-3ckzA:53.0 | 3k39H-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.53A | 3k39H-4cpnA:73.9 | 3k39H-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.47A | 3k39H-4cpnA:73.9 | 3k39H-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.67A | 3k39I-3ckzA:52.9 | 3k39I-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.73A | 3k39I-3ckzA:52.9 | 3k39I-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A) | 0.52A | 3k39I-4cpnA:73.9 | 3k39I-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | GLU A 116LEU A 131ASP A 148ARG A 153ARG A 373 | ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.2A)ZMR A 700 (-3.0A) | 1.50A | 3k39I-4cpnA:73.9 | 3k39I-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.66A | 3k39J-3ckzA:53.0 | 3k39J-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.72A | 3k39J-3ckzA:53.0 | 3k39J-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A) | 0.52A | 3k39J-4cpnA:74.0 | 3k39J-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.65A | 3k39K-3ckzA:52.9 | 3k39K-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.72A | 3k39K-3ckzA:52.9 | 3k39K-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A) | 0.53A | 3k39K-4cpnA:73.9 | 3k39K-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.47A | 3k39K-4cpnA:73.9 | 3k39K-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.67A | 3k39L-3ckzA:53.0 | 3k39L-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.72A | 3k39L-3ckzA:53.0 | 3k39L-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A) | 0.52A | 3k39L-4cpnA:73.9 | 3k39L-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.47A | 3k39L-4cpnA:73.9 | 3k39L-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.66A | 3k39M-3ckzA:53.0 | 3k39M-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.72A | 3k39M-3ckzA:53.0 | 3k39M-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.52A | 3k39M-4cpnA:73.9 | 3k39M-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.66A | 3k39N-3ckzA:53.0 | 3k39N-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.72A | 3k39N-3ckzA:53.0 | 3k39N-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.54A | 3k39N-4cpnA:73.9 | 3k39N-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.66A | 3k39O-3ckzA:53.0 | 3k39O-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.73A | 3k39O-3ckzA:53.0 | 3k39O-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.55A | 3k39O-4cpnA:73.9 | 3k39O-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.66A | 3k39P-3ckzA:53.0 | 3k39P-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.72A | 3k39P-3ckzA:53.0 | 3k39P-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | GLU A 116LEU A 131ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.55A | 3k39P-4cpnA:73.9 | 3k39P-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 ( 4.8A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.36A | 3sanA-3ckzA:69.9 | 3sanA-3ckzA:57.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.30A | 3sanA-3ckzA:69.9 | 3sanA-3ckzA:57.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.40A | 3sanA-4cpnA:54.1 | 3sanA-4cpnA:32.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.65A | 3sanA-3ckzA:69.9 | 3sanA-3ckzA:57.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | ASP A 148ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.15A | 3sanA-4cpnA:53.9 | 3sanA-4cpnA:32.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 ( 4.8A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.37A | 3sanB-3ckzA:69.8 | 3sanB-3ckzA:57.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.31A | 3sanB-3ckzA:69.8 | 3sanB-3ckzA:57.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.41A | 3sanB-4cpnA:54.0 | 3sanB-4cpnA:32.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.65A | 3sanB-3ckzA:69.8 | 3sanB-3ckzA:57.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | ASP A 148ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.12A | 3sanB-4cpnA:54.1 | 3sanB-4cpnA:32.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.37A | 3ti5A-3ckzA:75.0 | 3ti5A-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.27A | 3ti5A-3ckzA:75.0 | 3ti5A-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.39A | 3ti5A-4cpnA:53.8 | 3ti5A-4cpnA:32.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.72A | 3ti5A-3ckzA:75.0 | 3ti5A-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.14A | 3ti5A-4cpnA:53.8 | 3ti5A-4cpnA:32.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.37A | 3ti5B-3ckzA:75.0 | 3ti5B-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.27A | 3ti5B-3ckzA:75.0 | 3ti5B-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.41A | 3ti5B-4cpnA:53.8 | 3ti5B-4cpnA:32.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.72A | 3ti5B-3ckzA:75.0 | 3ti5B-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.14A | 3ti5B-4cpnA:53.8 | 3ti5B-4cpnA:32.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151TRP A 178GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.39A | 3ticA-3ckzA:64.0 | 3ticA-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.37A | 3ticA-3ckzA:64.0 | 3ticA-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ALA A 244GLU A 274GLU A 275ARG A 115TYR A 408 | ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A)ZMR A 700 (-4.6A) | 1.48A | 3ticA-4cpnA:55.2 | 3ticA-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148TRP A 176GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)NoneZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.45A | 3ticA-4cpnA:55.2 | 3ticA-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156ILE A 222ARG A 224 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneZMR A 469 (-4.4A) | 0.66A | 3ticA-3ckzA:64.0 | 3ticA-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ARG A 149ARG A 153ILE A 220ARG A 222 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneZMR A 700 (-3.8A) | 0.22A | 3ticA-4cpnA:55.2 | 3ticA-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.40A | 3ticB-3ckzA:64.0 | 3ticB-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.36A | 3ticB-3ckzA:64.0 | 3ticB-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.48A | 3ticB-4cpnA:55.1 | 3ticB-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.69A | 3ticB-3ckzA:64.0 | 3ticB-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.10A | 3ticB-4cpnA:55.1 | 3ticB-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.41A | 3ticC-3ckzA:64.0 | 3ticC-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.37A | 3ticC-3ckzA:64.0 | 3ticC-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.47A | 3ticC-4cpnA:55.1 | 3ticC-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.69A | 3ticC-3ckzA:64.0 | 3ticC-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.11A | 3ticC-4cpnA:55.1 | 3ticC-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.40A | 3ticD-3ckzA:64.1 | 3ticD-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.35A | 3ticD-3ckzA:64.1 | 3ticD-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.47A | 3ticD-4cpnA:55.2 | 3ticD-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.65A | 3ticD-3ckzA:64.1 | 3ticD-3ckzA:41.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ARG A 149ARG A 153TRP A 176ILE A 220 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.11A | 3ticD-4cpnA:55.0 | 3ticD-4cpnA:30.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.41A | 4b7nA-3ckzA:74.2 | 4b7nA-3ckzA:90.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.31A | 4b7nA-3ckzA:74.2 | 4b7nA-3ckzA:90.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.47A | 4b7nA-4cpnA:53.4 | 4b7nA-4cpnA:34.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 222GLU A 274GLU A 275ARG A 115TYR A 408 | ZMR A 700 (-3.8A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A)ZMR A 700 (-4.6A) | 1.48A | 4b7nA-4cpnA:53.4 | 4b7nA-4cpnA:34.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.83A | 4b7nA-3ckzA:74.2 | 4b7nA-3ckzA:90.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.13A | 4b7nA-4cpnA:53.4 | 4b7nA-4cpnA:34.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.41A | 4b7qA-3ckzA:74.1 | 4b7qA-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.26A | 4b7qA-3ckzA:74.1 | 4b7qA-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.45A | 4b7qA-4cpnA:53.2 | 4b7qA-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.90A | 4b7qA-3ckzA:74.1 | 4b7qA-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.25A | 4b7qA-4cpnA:53.2 | 4b7qA-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.48A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.28A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.31A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.49A | 4b7qB-4cpnA:53.2 | 4b7qB-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.73A | 4b7qB-3ckzA:74.1 | 4b7qB-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | LEU A 131ARG A 149ARG A 153TRP A 176 | NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.19A | 4b7qB-4cpnA:53.2 | 4b7qB-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.38A | 4b7qC-3ckzA:74.3 | 4b7qC-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.28A | 4b7qC-3ckzA:74.3 | 4b7qC-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.46A | 4b7qC-4cpnA:53.3 | 4b7qC-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.84A | 4b7qC-3ckzA:74.3 | 4b7qC-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.16A | 4b7qC-4cpnA:53.3 | 4b7qC-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.40A | 4b7qD-3ckzA:74.0 | 4b7qD-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.31A | 4b7qD-3ckzA:74.0 | 4b7qD-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.49A | 4b7qD-4cpnA:53.4 | 4b7qD-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 222GLU A 274GLU A 275ARG A 115TYR A 408 | ZMR A 700 (-3.8A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A)ZMR A 700 (-4.6A) | 1.43A | 4b7qD-4cpnA:53.4 | 4b7qD-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.73A | 4b7qD-3ckzA:74.0 | 4b7qD-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ARG A 149ARG A 153TRP A 176ILE A 220 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNone | 0.27A | 4b7qD-4cpnA:53.4 | 4b7qD-4cpnA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.45A | 4cpnA-3ckzA:53.7 | 4cpnA-3ckzA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.08A | 4cpnA-3ckzA:53.7 | 4cpnA-3ckzA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.69A | 4cpnA-3ckzA:53.7 | 4cpnA-3ckzA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.60A | 4cpnB-3ckzA:53.6 | 4cpnB-3ckzA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.42A | 4cpzA-3ckzA:53.5 | 4cpzA-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.22A | 4cpzA-4cpnA:75.5 | 4cpzA-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178 | NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.63A | 4cpzA-3ckzA:53.4 | 4cpzA-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ASP A 148ARG A 149ARG A 153TRP A 176 | NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.12A | 4cpzA-4cpnA:75.5 | 4cpzA-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.39A | 4cpzB-3ckzA:53.4 | 4cpzB-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.18A | 4cpzB-4cpnA:75.4 | 4cpzB-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.73A | 4cpzB-3ckzA:53.4 | 4cpzB-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ASP A 148ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.13A | 4cpzB-4cpnA:75.4 | 4cpzB-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.41A | 4cpzC-3ckzA:53.4 | 4cpzC-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.20A | 4cpzC-4cpnA:75.4 | 4cpzC-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.78A | 4cpzC-3ckzA:53.4 | 4cpzC-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.17A | 4cpzC-4cpnA:75.4 | 4cpzC-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.45A | 4cpzD-3ckzA:53.3 | 4cpzD-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.24A | 4cpzD-4cpnA:75.5 | 4cpzD-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.74A | 4cpzD-3ckzA:53.3 | 4cpzD-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | ASP A 148ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.13A | 4cpzD-4cpnA:75.5 | 4cpzD-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.45A | 4cpzE-3ckzA:53.2 | 4cpzE-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.24A | 4cpzE-4cpnA:75.0 | 4cpzE-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.80A | 4cpzE-3ckzA:53.2 | 4cpzE-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.14A | 4cpzE-4cpnA:75.0 | 4cpzE-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.44A | 4cpzF-3ckzA:53.3 | 4cpzF-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.27A | 4cpzF-4cpnA:75.1 | 4cpzF-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.80A | 4cpzF-3ckzA:53.3 | 4cpzF-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.12A | 4cpzF-4cpnA:75.1 | 4cpzF-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.36A | 4cpzG-3ckzA:53.1 | 4cpzG-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.26A | 4cpzG-4cpnA:74.8 | 4cpzG-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.80A | 4cpzG-3ckzA:53.1 | 4cpzG-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.17A | 4cpzG-4cpnA:74.8 | 4cpzG-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.51A | 4cpzH-3ckzA:53.2 | 4cpzH-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.26A | 4cpzH-4cpnA:74.8 | 4cpzH-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)None | 0.79A | 4cpzH-3ckzA:53.2 | 4cpzH-3ckzA:32.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149ARG A 153TRP A 176 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)None | 0.19A | 4cpzH-4cpnA:74.8 | 4cpzH-4cpnA:98.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.30A | 4i00A-3ckzA:64.4 | 4i00A-3ckzA:46.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 149ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.43A | 4i00A-4cpnA:53.1 | 4i00A-4cpnA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 156TRP A 178ILE A 222 | NoneZMR A 469 (-3.4A)NoneNone | 0.71A | 4i00A-3ckzA:64.4 | 4i00A-3ckzA:46.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134TRP A 178ILE A 222ASN A 294 | NoneNoneNoneZMR A 469 (-3.9A) | 0.95A | 4i00A-3ckzA:64.4 | 4i00A-3ckzA:46.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ARG A 153TRP A 176ILE A 220ASN A 293 | NoneZMR A 700 (-4.2A)NoneNoneZMR A 700 ( 3.9A) | 0.97A | 4i00A-4cpnA:53.0 | 4i00A-4cpnA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.57A | 4mwrA-3ckzA:64.3 | 4mwrA-3ckzA:48.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.34A | 4mwrA-3ckzA:64.3 | 4mwrA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.50A | 4mwrA-4cpnA:54.2 | 4mwrA-4cpnA:28.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 6 / 12 | ARG A 222ALA A 244GLU A 274GLU A 275ARG A 115TYR A 408 | ZMR A 700 (-3.8A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A)ZMR A 700 (-4.6A) | 1.49A | 4mwrA-4cpnA:54.2 | 4mwrA-4cpnA:28.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152TRP A 178ILE A 222 | NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)NoneNone | 0.15A | 4mwrA-3ckzA:64.3 | 4mwrA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | LEU A 131ASP A 148ARG A 149TRP A 176ILE A 220 | NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)NoneNone | 0.14A | 4mwrA-4cpnA:54.2 | 4mwrA-4cpnA:28.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 151ARG A 152ILE A 222ARG A 224GLU A 227 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)NoneZMR A 469 (-4.4A)ZMR A 469 (-3.5A) | 1.42A | 4mwvA-3ckzA:64.2 | 4mwvA-3ckzA:48.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 151ARG A 152TRP A 178GLU A 276ARG A 292 | ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)NoneZMR A 469 (-2.8A)ZMR A 469 (-3.0A) | 1.47A | 4mwvA-3ckzA:64.2 | 4mwvA-3ckzA:48.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNoneZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-4.7A) | 0.69A | 4mwvA-3ckzA:64.2 | 4mwvA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ASP A 148ARG A 149ILE A 220ARG A 222GLU A 225 | ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)NoneZMR A 700 (-3.8A)ZMR A 700 (-3.5A) | 1.26A | 4mwvA-4cpnA:54.2 | 4mwvA-4cpnA:28.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153TRP A 176ILE A 220ARG A 222GLU A 274GLU A 275ARG A 291TYR A 408 | ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNoneZMR A 700 (-3.8A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 0.46A | 4mwvA-4cpnA:54.2 | 4mwvA-4cpnA:28.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | GLU A 225ARG A 149ILE A 220ARG A 291TYR A 408 | ZMR A 700 (-3.5A)ZMR A 700 (-4.0A)NoneZMR A 700 (-2.8A)ZMR A 700 (-4.6A) | 1.47A | 4mwvA-4cpnA:54.2 | 4mwvA-4cpnA:28.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118GLU A 227ARG A 371 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-2.9A) | 0.14A | 4mwvA-3ckzA:64.2 | 4mwvA-3ckzA:48.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 115GLU A 225ARG A 373 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.0A) | 0.24A | 4mwvA-4cpnA:54.2 | 4mwvA-4cpnA:28.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227GLU A 276GLU A 277ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.58A | 4mwxA-3ckzA:64.2 | 4mwxA-3ckzA:47.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 11 / 12 | ARG A 115GLU A 116ASP A 148ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.58A | 4mwxA-4cpnA:54.1 | 4mwxA-4cpnA:28.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 6 / 12 | ARG A 222ALA A 244GLU A 274GLU A 275ARG A 115TYR A 408 | ZMR A 700 (-3.8A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.9A)ZMR A 700 (-4.6A) | 1.44A | 4mwxA-4cpnA:54.1 | 4mwxA-4cpnA:28.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152TRP A 178ILE A 222 | ZMR A 469 (-3.9A)NoneNone | 0.10A | 4mwxA-3ckzA:64.2 | 4mwxA-3ckzA:47.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 149TRP A 176ILE A 220 | ZMR A 700 (-4.0A)NoneNone | 0.12A | 4mwxA-4cpnA:54.1 | 4mwxA-4cpnA:28.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ARG A 224GLU A 227GLU A 276GLU A 277TYR A 406 | ZMR A 469 (-3.5A)NoneZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneZMR A 469 ( 4.6A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-4.7A) | 0.71A | 4mx0A-3ckzA:64.1 | 4mx0A-3ckzA:47.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | GLU A 116LEU A 131ARG A 149ARG A 153TRP A 176SER A 177ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275TYR A 408 | ZMR A 700 (-3.5A)NoneZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneZMR A 700 ( 4.6A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-4.6A) | 0.56A | 4mx0A-4cpnA:54.2 | 4mx0A-4cpnA:28.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ASP A 151ARG A 371 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-2.9A) | 0.19A | 4mx0A-3ckzA:64.1 | 4mx0A-3ckzA:47.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | ARG A 115ASP A 148ARG A 373 | ZMR A 700 (-2.9A)ZMR A 700 (-3.3A)ZMR A 700 (-3.0A) | 0.23A | 4mx0A-4cpnA:54.2 | 4mx0A-4cpnA:28.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151GLU A 227GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 ( 4.8A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.54A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294TYR A 347ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 ( 4.8A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.45A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 10 / 12 | ARG A 115GLU A 116ASP A 148GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.56A | 4wa5A-4cpnA:52.8 | 4wa5A-4cpnA:31.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 10 / 12 | ARG A 115GLU A 116GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.43A | 4wa5A-4cpnA:52.8 | 4wa5A-4cpnA:31.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | ARG A 152ARG A 156TRP A 178ILE A 222 | ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)NoneNone | 0.75A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | ARG A 152TRP A 178ILE A 222ARG A 224 | ZMR A 469 (-3.9A)NoneNoneZMR A 469 (-4.4A) | 0.30A | 4wa5A-3ckzA:67.5 | 4wa5A-3ckzA:57.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 5 | ARG A 149ARG A 153TRP A 176ILE A 220ARG A 222 | ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)NoneNoneZMR A 700 (-3.8A) | 0.54A | 4wa5A-4cpnA:52.8 | 4wa5A-4cpnA:31.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A06_D_SORD1343_0 (ALDOSE-ALDOSEOXIDOREDUCTASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 5 | ALA A 130ARG A 153HIS A 100ALA A 440 | NoneZMR A 700 (-4.2A)NoneNone | 1.08A | 5a06C-4cpnA:undetectable5a06D-4cpnA:undetectable | 5a06C-4cpnA:21.055a06D-4cpnA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_A_KANA600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.45A | 5iqbA-3ckzA:0.0 | 5iqbA-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_B_KANB600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 11 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.44A | 5iqbB-3ckzA:0.0 | 5iqbB-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_B_KANB600_1 (BIFUNCTIONAL AAC/APH) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 11 | SER A 177ASP A 196GLU A 116GLU A 275GLU A 225 | ZMR A 700 ( 4.6A)NoneZMR A 700 (-3.5A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A) | 1.49A | 5iqbB-4cpnA:undetectable | 5iqbB-4cpnA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_C_KANC600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 11 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.46A | 5iqbC-3ckzA:0.0 | 5iqbC-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_D_KAND600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.46A | 5iqbD-3ckzA:0.0 | 5iqbD-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_A_51GA600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.44A | 5iqcA-3ckzA:0.0 | 5iqcA-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_A_51GA600_1 (BIFUNCTIONAL AAC/APH) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 10 | SER A 177ASP A 196GLU A 116GLU A 275GLU A 225 | ZMR A 700 ( 4.6A)NoneZMR A 700 (-3.5A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A) | 1.49A | 5iqcA-4cpnA:0.4 | 5iqcA-4cpnA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_B_51GB600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.47A | 5iqcB-3ckzA:0.8 | 5iqcB-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_C_51GC600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.47A | 5iqcC-3ckzA:0.0 | 5iqcC-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_D_51GD600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.45A | 5iqcD-3ckzA:undetectable | 5iqcD-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_D_51GD600_1 (BIFUNCTIONAL AAC/APH) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 10 | SER A 177ASP A 196GLU A 116GLU A 275GLU A 225 | ZMR A 700 ( 4.6A)NoneZMR A 700 (-3.5A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A) | 1.49A | 5iqcD-4cpnA:0.0 | 5iqcD-4cpnA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQE_A_NMYA600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 11 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.47A | 5iqeA-3ckzA:0.0 | 5iqeA-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQE_D_NMYD600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.45A | 5iqeD-3ckzA:undetectable | 5iqeD-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQE_D_NMYD600_1 (BIFUNCTIONAL AAC/APH) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | SER A 177ASP A 196GLU A 116GLU A 275GLU A 225 | ZMR A 700 ( 4.6A)NoneZMR A 700 (-3.5A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A) | 1.49A | 5iqeD-4cpnA:0.0 | 5iqeD-4cpnA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQG_A_51GA600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.49A | 5iqgA-3ckzA:0.0 | 5iqgA-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQG_B_51GB600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.50A | 5iqgB-3ckzA:0.2 | 5iqgB-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQG_C_51GC600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.50A | 5iqgC-3ckzA:1.0 | 5iqgC-3ckzA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQG_D_51GD600_1 (BIFUNCTIONAL AAC/APH) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | ZMR A 469 ( 4.6A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.5A) | 1.49A | 5iqgD-3ckzA:0.1 | 5iqgD-3ckzA:21.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.60A | 5l17A-3ckzA:64.6 | 5l17A-3ckzA:47.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.51A | 5l17A-4cpnA:54.4 | 5l17A-4cpnA:28.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_2 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152TRP A 178ILE A 222 | NoneZMR A 469 (-3.9A)NoneNone | 0.16A | 5l17A-3ckzA:64.6 | 5l17A-3ckzA:47.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L17_A_ZMRA512_2 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 4 / 4 | LEU A 131ARG A 149TRP A 176ILE A 220 | NoneZMR A 700 (-4.0A)NoneNone | 0.17A | 5l17A-4cpnA:54.4 | 5l17A-4cpnA:28.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.31A | 6ekuA-3ckzA:11.7 | 6ekuA-3ckzA:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 5 / 12 | ARG A 115GLU A 275ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.37A | 6ekuA-4cpnA:14.0 | 6ekuA-4cpnA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 276ARG A 292ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.56A | 6hcxA-3ckzA:64.5 | 6hcxA-3ckzA:10.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 12 / 12 | ARG A 115GLU A 116ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274ARG A 291ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-2.8A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.52A | 6hcxA-4cpnA:54.2 | 6hcxA-4cpnA:20.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_1 (NEURAMINIDASE) |
3ckz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | TRP A 178ILE A 222GLU A 277 | NoneNoneZMR A 469 (-3.7A) | 0.07A | 6hcxA-3ckzA:64.5 | 6hcxA-3ckzA:10.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_1 (NEURAMINIDASE) |
4cpn | NEURAMINIDASE (InfluenzaBvirus) | 3 / 3 | TRP A 176ILE A 220GLU A 275 | NoneNoneZMR A 700 (-3.4A) | 0.11A | 6hcxA-4cpnA:54.2 | 6hcxA-4cpnA:20.34 |